Terns Pharmaceuticals (TERN) EPS (Basic) (2020 - 2023)
Historic EPS (Basic) for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to -$0.29.
- Terns Pharmaceuticals' EPS (Basic) fell 7058.82% to -$0.29 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.27, marking a year-over-year increase of 2573.1%. This contributed to the annual value of -$1.12 for FY2024, which is 1181.1% up from last year.
- Terns Pharmaceuticals' EPS (Basic) amounted to -$0.29 in Q4 2023, which was down 7058.82% from -$0.42 recorded in Q3 2023.
- Over the past 5 years, Terns Pharmaceuticals' EPS (Basic) peaked at $8.45 during Q4 2020, and registered a low of -$41.69 during Q1 2020.
- Its 4-year average for EPS (Basic) is -$6.84, with a median of -$0.46 in 2022.
- Within the past 5 years, the most significant YoY rise in Terns Pharmaceuticals' EPS (Basic) was 9875.57% (2021), while the steepest drop was 10674.56% (2021).
- Over the past 4 years, Terns Pharmaceuticals' EPS (Basic) (Quarter) stood at $8.45 in 2020, then crashed by 106.75% to -$0.57 in 2021, then soared by 70.18% to -$0.17 in 2022, then plummeted by 70.59% to -$0.29 in 2023.
- Its last three reported values are -$0.29 in Q4 2023, -$0.42 for Q3 2023, and -$0.25 during Q2 2023.